CJC-1295 with DAC – Research-Grade Long-Acting GHRH Analog

CJC-1295 with DAC is a synthetically modified growth hormone–releasing hormone (GHRH) analog incorporating a Drug Affinity Complex (DAC) conjugation. The DAC modification enables covalent interaction with circulating albumin in experimental models, resulting in an extended peptide persistence profile compared to non-conjugated GHRH fragments.

In laboratory research environments, CJC-1295 with DAC is utilized as a reference material for studying receptor–ligand interaction dynamics, peptide half-life modification strategies, and structure–function relationships associated with long-acting peptide analog systems.

Unlike short native peptide fragments, CJC-1295 with DAC represents a chemically engineered conjugated peptide construct designed to support controlled in vitro and mechanistic research. This material is intended strictly for laboratory research use only and is not designed for human or veterinary application.

Related research compounds

CJC-1295 (No DAC) · Sermorelin · Tesamorelin · Ipamorelin · CJC-1295 (w/o DAC) + Ipamorelin (Blend)

Documentation and methods

Analytical testing · How to read a COA · Batch COAs · Storage and handling · What are research peptides

Important Information About This Research Product

1. 1 Your vials are not empty. The lyophilized material may collect at the bottom of the vial and can appear minimal prior to inspection.
2. 2 All products are supplied as lyophilized (freeze-dried) powder and require reconstitution. Bacteriostatic water is not supplied.
3. 3 Store in a dry, cool, and dark environment away from UV exposure. For optimal preservation, storage at approximately 4°C is recommended.
4. 4 This material is strictly for laboratory and research use only. No instructions regarding reconstitution, dosing, or administration can be provided.